Search Results - "Chaturvedi, Ashok K."

Dispersion as an important step in the Candida albicans biofilm developmental cycle by Uppuluri, Priya, Chaturvedi, Ashok K, Srinivasan, Anand, Banerjee, Mohua, Ramasubramaniam, Anand K, Köhler, Julia R, Kadosh, David, Lopez-Ribot, Jose L

“…Biofilms are dynamic microbial communities in which transitions between planktonic and sessile modes of growth occur interchangeably in response to different…”
Get full text

Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation by Ajetunmobi, Olabayo H, Chaturvedi, Ashok K, Badali, Hamid, Vaccaro, Alessandra, Najvar, Laura, Wormley, Jr, Floyd L, Wiederhold, Nathan P, Patterson, Thomas F, Lopez-Ribot, Jose L

“…Candida spp. are opportunistic yeasts capable of forming biofilms, which contribute to resistance, increasing the urgency for new effective antifungal…”
Get full text

Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice by Chaturvedi, Ashok K, Hameed, Rumanasma S, Wozniak, Karen L, Hole, Camaron R, Leopold Wager, Chrissy M, Weintraub, Susan T, Lopez-Ribot, Jose L, Wormley, Jr, Floyd L

“…Cryptococcus gattii is a fungal pathogen that can cause life-threatening respiratory and disseminated infections in immune-competent and immune-suppressed…”
Get full text

Characteristics of Candida albicans Biofilms Grown in a Synthetic Urine Medium by Uppuluri, Priya, Dinakaran, Hemamalini, Thomas, Derek P, Chaturvedi, Ashok K, Lopez-Ribot, Jose L

“…Urinary tract infections (UTIs) are the most common type of nosocomial infection, and Candida albicans is the most frequent organism causing fungal UTIs…”
Get full text

Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance by Uppuluri, Priya, Chaturvedi, Ashok K, Lopez-Ribot, Jose L

“…Candida albicans biofilms on most medical devices are exposed to a flow of body fluids that provide water and nutrients to the fungal cells. While C. albicans…”
Get full text

High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms by Ajetunmobi, Olabayo H., Wall, Gina, Vidal Bonifacio, Bruna, Martinez Delgado, Lucero A., Chaturvedi, Ashok K., Najvar, Laura K., Wormley, Floyd L., Patterson, Hoja P., Wiederhold, Nathan P., Patterson, Thomas F., Lopez-Ribot, Jose L.

“…Candidiasis is one of the most frequent nosocomial infections affecting an increasing number of at-risk patients. Candida albicans remains the most frequent…”
Get full text

Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes by Van Dyke, Marley C Caballero, Chaturvedi, Ashok K, Hardison, Sarah E, Leopold Wager, Chrissy M, Castro-Lopez, Natalia, Hole, Camaron R, Wozniak, Karen L, Wormley, Jr, Floyd L

“…Cryptococcosis is a fungal disease caused by multiple serotypes; particularly (serotypes A and D) and (serotypes B and C). To date, there is no clinically…”
Get full text

Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis by Saville, Stephen P, Lazzell, Anna L, Chaturvedi, Ashok K, Monteagudo, Carlos, Lopez-Ribot, Jose L

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Use of a Genetically Engineered Strain To Evaluate the Pathogenic Potential of Yeast Cell and Filamentous Forms during Candida albicans Systemic Infection in Immunodeficient Mice by SAVILLE, Stephen P, LAZZELL, Anna L, CHATURVEDI, Ashok K, MONTEAGUDO, Carlos, LOPEZ-RIBOT, Jose L

“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Synthesis and biological evaluation of novel 1,4-naphthoquinone derivatives as antibacterial and antiviral agents by Tandon, Vishnu K., Yadav, Dharmendra B., Singh, Ravindra V., Vaish, Meenu, Chaturvedi, Ashok K., Shukla, Praveen K.

“…The synthesis, and antibacterial and antiviral activities of 5– 24 are described. A series of 1,4-naphthoquinone derivatives were synthesized and evaluated for…”
Get full text

Physiologic Expression of the Candida albicans Pescadillo Homolog Is Required for Virulence in a Murine Model of Hematogenously Disseminated Candidiasis by Uppuluri, Priya, Chaturvedi, Ashok K, Jani, Niketa, Pukkila-Worley, Read, Monteagudo, Carlos, Mylonakis, Eleftherios, Köhler, Julia R, Lopez Ribot, Jose L

“…Classifications Services EC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development by Wall, Gina, Chaturvedi, Ashok K, Wormley, Jr, Floyd L, Wiederhold, Nathan P, Patterson, Hoja P, Patterson, Thomas F, Lopez-Ribot, José L

“…Since its original isolation in 2009, has spread across the globe as a causative agent of invasive candidiasis. is typically intrinsically resistant to…”
Get full text

Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease by Chaturvedi, Ashok K, Lazzell, Anna L, Saville, Stephen P, Wormley, Jr, Floyd L, Monteagudo, Carlos, Lopez-Ribot, Jose L

“…Understanding the pathogenesis of infectious disease requires the examination and successful integration of parameters related to both microbial virulence and…”
Get full text

Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis by Chaturvedi, Ashok K, Kavishwar, A, Shiva Keshava, G B, Shukla, P K

“…Most of the biological functions related to pathogenicity and virulence reside in the fungal cell wall, which, being the outermost part of the cell, mediates…”
Get full text

In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis by Vila, Taissa Vieira Machado, Chaturvedi, Ashok K, Rozental, Sonia, Lopez-Ribot, Jose L

“…The generation of a new antifungal against Candida albicans biofilms has become a major priority, since biofilm formation by this opportunistic pathogenic…”
Get full text

Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation by Romo, Jesus A, Pierce, Christopher G, Chaturvedi, Ashok K, Lazzell, Anna L, McHardy, Stanton F, Saville, Stephen P, Lopez-Ribot, Jose L

“…remains the main etiologic agent of candidiasis, the most common fungal infection and now the third most frequent infection in U.S. hospitals. The scarcity of…”
Get full text

Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi by Wiederhold, Nathan P, Patterson, Thomas F, Srinivasan, Anand, Chaturvedi, Ashok K, Fothergill, Annette W, Wormley, Floyd L, Ramasubramanian, Anand K, Lopez-Ribot, José L

“…Repositioning old drugs can significantly decrease the time and effort that it takes to develop novel antifungal therapeutics, which represents a pressing and…”
Get full text

Methodology for Anti-Cryptococcal Vaccine Development by Chaturvedi, Ashok K, Wormley, Jr, Floyd L

“…Cryptococcus neoformans and Cryptococcus gattii, the predominant etiological agents of cryptococcosis, are fungal pathogens that cause disease ranging from a…”
Get more information

A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance by Pierce, Christopher G, Chaturvedi, Ashok K, Lazzell, Anna L, Powell, Alexander T, Saville, Stephen P, McHardy, Stanton F, Lopez-Ribot, Jose L

“…Background/Objectives: Candida albicans is the principal causative agent of candidiasis, the most common fungal infection in humans. Candidiasis represents the…”
Get full text

New antifungal flavonoid glycoside from Vitex negundo by Sathiamoorthy, B., Gupta, Prasoon, Kumar, Manmeet, Chaturvedi, Ashok K., Shukla, P.K., Maurya, Rakesh

“…New flavone glycoside was isolated along with five known compounds from the leaves of Vitex negundo and evaluated for their antifungal and antibacterial…”
Get full text